respiratory
Risk factors

Champix not linked to heart disease, depression: study


The tobacco quitting drug varenicline (Champix™) is not likely to increase the risk of self-harm or depression or cardiovascular disease, a large UK study reports.  The drug was associated with a 20% reduced risk of ischaemic heart disease a 34% lower risk of depression and a 44% lower risk of self harm compared to users ...

Already a member?

Enter your email to keep reading.


OR